Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Other Accumulated Expenses (2024 - 2025)

Mangoceuticals' Other Accumulated Expenses history spans 2 years, with the latest figure at $20056.0 for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 94.62% to $20056.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $20056.0, a 94.62% decrease, with the full-year FY2025 number at $20056.0, down 94.62% from a year prior.
  • Other Accumulated Expenses hit $20056.0 in Q4 2025 for Mangoceuticals, down from $160684.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for MGRX hit a ceiling of $400000.0 in Q2 2024 and a floor of $20056.0 in Q4 2025.